Details for Patent: 6,576,659
✉ Email this page to a colleague
Title: | Use of oxandrolone in the treatment of burns an other wounds |
Abstract: | The subject invention provides a method of treating burn-induced weight loss in a burn patient which comprises administering a therapeutically effective amount of an oxandrolone to the patient. The invention also provides a method of treating a wound in a patient suffering from a wound which comprises administering a therapeutically effective amount of an oxandrolone to the patient. The subject invention further provides a method of treating burn-induced weight loss in a burn patient which comprises administering a therapeutically effective amount of an oxandrolone in conjunction with a protein supplement to the patient. |
Inventor(s): | Fishbein; Don (Westfield, NJ) |
Assignee: | Bio-Technology General Corp. (Middlesex, NJ) |
Filing Date: | Dec 05, 1997 |
Application Number: | 08/985,734 |
Claims: | 1. A method of treating a skin wound in a patient suffering from the skin wound which comprises administering orally or topically a therapeutically effective amount of oxandrolone to the patient, wherein the skin wound is selected from the group consisting of a burn, an ulcer and a skin graft. 2. A method according to claim 1, wherein the skin wound is an ulcer. 3. A method according to claim 2, wherein the ulcer is a decubitus ulcer or a diabetic ulcer. 4. A method according to claim 1, wherein the skin wound comprises a skin graft. 5. A method according to claim 1 wherein the amount of oxandrolone is about 1-100 mg per day. 6. A method according to claim 5 wherein the amount of oxandrolone is about 20 mg per day. 7. A method according to claim 5 wherein the amount of oxandrolone is about 80 mg per day. 8. A method according to claim 1 wherein oxandrolone is in a solid dosage form. 9. A method according to claim 1 wherein oxandrolone is in a liquid dosage form. 10. A method according to claim 1 wherein oxandrolone is in a sustained-release formulation. 11. A method according to claim 1, wherein the skin wound is a burn. 12. A method of treating burn-induced weight loss in a burn patient which comprises administering orally or topically a therapeutically effective amount of oxandrolone in conjunction with a protein supplement to the patient. 13. A method according to claim 12 wherein the amount of oxandrolone is about 1-100 mg per day. 14. A method according to claim 12 wherein the amount of oxandrolone is about 20 mg per day. 15. A method according to claim 12 wherein the amount of oxandrolone is about 80 mg per day. 16. A method according to claim 12 wherein oxandrolone is administered orally. 17. A method according to claim 12 wherein oxandrolone is administered topically. 18. A method according to claim 12 wherein oxandrolone is in a solid dosage form. 19. A method according to claim 12 wherein oxandrolone is in a liquid dosage form. 20. A method according to claim 12 wherein oxandrolone is in a sustained-release formulation. |